Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway

Leukemia. 2007 Apr;21(4):595-603. doi: 10.1038/sj.leu.2404540. Epub 2007 Feb 15.

Abstract

Besides its matrix metalloproteinases inhibitory activity, TIMP-1 exhibits other biological activities such as cell survival and proliferation. The intracellular signalling pathway elicited by TIMP-1 begins to be elucidated. We have shown previously that the caspase-3 and the p38alpha MAP kinase were activated during TIMP-1-induced UT-7 cells erythroid differentiation. In this study, we demonstrated that TIMP-1 differentiating effect can be extended to the IL-3-dependent myeloid murine 32D cell line and human erythroid progenitors derived from cord blood CD34(+) cells. By performing small interfering RNA transfection and using chemical inhibitors, we evidenced that caspase-3 was involved in TIMP-1 differentiating effect. We then identified the MEKK1 kinase as a caspase-3 substrate and demonstrated that the MEKK1/MEK6/p38alpha pathway was activated downstream the caspase-3 in TIMP-1-induced hematopoietic differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / physiology
  • Antigens, CD34 / physiology
  • Caspase 3 / metabolism*
  • Cell Differentiation
  • Cell Line
  • Hematopoiesis / physiology*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / physiology*
  • Humans
  • MAP Kinase Kinase 6 / genetics
  • MAP Kinase Kinase 6 / metabolism*
  • MAP Kinase Kinase Kinase 1 / genetics
  • MAP Kinase Kinase Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 14 / metabolism*
  • RNA, Small Interfering / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism*

Substances

  • Antigens, CD
  • Antigens, CD34
  • RNA, Small Interfering
  • Tissue Inhibitor of Metalloproteinase-1
  • Mitogen-Activated Protein Kinase 14
  • MAP Kinase Kinase Kinase 1
  • MAP Kinase Kinase 6
  • Caspase 3